EVLO
Evelo Biosciences, Inc.
OTCHealthcareBiotechnologyUS
Company Profile
CEO
Craig R. Jalbert
IPO Date
2018-05-08
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Evelo Biosciences, Inc.
CEO
Craig R. Jalbert
IPO Date
2018-05-08
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| 3,163 |
| $0.33 |
| 8 Nov 2023 | Bodmer Mark | CSO, President of R&D | M-Exempt | Disposed | 6,625 | $0.00 |
| 8 Nov 2023 | McHale Duncan | Chief Medical Officer | M-Exempt | Acquired | 6,500 | $0.00 |
| 8 Nov 2023 | McHale Duncan | Chief Medical Officer | S-Sale | Disposed | 3,103 | $0.33 |
| 8 Nov 2023 | McHale Duncan | Chief Medical Officer | M-Exempt | Disposed | 6,500 | $0.00 |
| 8 Nov 2023 | Thorell Marella | Chief Financial Officer | M-Exempt | Acquired | 6,500 | $0.00 |
| 8 Nov 2023 | Thorell Marella | Chief Financial Officer | S-Sale | Disposed | 1,811 | $0.33 |
| 8 Nov 2023 | Thorell Marella | Chief Financial Officer | M-Exempt | Disposed | 6,500 | $0.00 |
| 8 Nov 2023 | GILL SIMBA | director, officer: President & CEO | M-Exempt | Acquired | 1,172 | $0.00 |